As mentioned above, increased sensitivity to insulin-mediated signaling in GPx1 knockout mice is offset by increased ROS in the pancreas and decreased plasma insulin in these mice
Statistical analysis The normality of variables was evaluated using the Kolmogorov-Smirnov test and visual tools like Q-Q plots
J Plant Physiol 238:1219
In the SUSTAIN clinical trial program evaluating subcutaneous semaglutide for type 2 diabetes, once-weekly dosing (0.5 mg or 1.0 mg) reduced HbA1c by 1.5% to 1.8% from baseline, with superior glycemic control compared to specific comparators in head-to-head trials (SUSTAIN-7 vs dulaglutide
There were also no differences at baseline or at maximal stimulation in gastrin-Gly, gastrin amide, CCK-amide, Islet Amyloid PolyPeptide (IAPP)-Gly and IAPP-amide levels between carriers and non-carriers (Extended Data Fig
Patients report a distinctly higher level of physical performance, faster recovery, better body composition, and improved overall quality of life compared to TRT alone